Phase III Clinical Study on the Efficacy and Safety of Semaglutide and Ozempic® in Patients With Type 2 Diabetes

NCT07046273 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

496

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes (T2DM)

Interventions

DRUG: F027
DRUG: Ozempic®

Sponsor

Shandong New Time Pharmaceutical Co., LTD